ETF constituents for IDNA

Below, a list of constituents for IDNA (iShares Genomics Immunology and Healthcare ETF) is shown. In total, IDNA consists of 59 securities.

Note: The data shown here is as of date May 30, 2025 (the latest that can be sourced directly from the fund provider).

Click here to go back to the full list of ETFs.

Ticker Name Sector Asset Class Market Value Weight (%)
TWST TWIST BIOSCIENCE CORP Health Care Equity 4990563.5 4.72
REGN REGENERON PHARMACEUTICALS INC Health Care Equity 4558575.0 4.31
4502 TAKEDA PHARMACEUTICAL LTD Health Care Equity 4411367.65 4.17
EXEL EXELIXIS INC Health Care Equity 4386476.23 4.15
MRNA MODERNA INC Health Care Equity 4302743.27 4.07
SWTX SPRINGWORKS THERAPEUTICS INC Health Care Equity 4299819.95 4.07
MRK MERCK & CO INC Health Care Equity 4292767.64 4.06
ROG ROCHE HOLDING PAR AG Health Care Equity 4267820.1 4.04
INCY INCYTE CORP Health Care Equity 4240723.2 4.01
BNTX BIONTECH SE ADR Health Care Equity 4202690.31 3.98
ACLX ARCELLX INC Health Care Equity 4140977.25 3.92
SAN SANOFI SA Health Care Equity 4104335.43 3.88
AZN ASTRAZENECA PLC Health Care Equity 4072182.49 3.85
6160 BEIGENE AG Health Care Equity 4053673.89 3.84
GMAB GENMAB Health Care Equity 4014641.74 3.8
GSK GLAXOSMITHKLINE Health Care Equity 3985784.8 3.77
RVMD REVOLUTION MEDICINES INC Health Care Equity 3834290.59 3.63
BCRX BIOCRYST PHARMACEUTICALS INC Health Care Equity 3475619.84 3.29
JANX JANUX THERAPEUTICS INC Health Care Equity 2770590.9 2.62
NVAX NOVAVAX INC Health Care Equity 2249490.6 2.13
302440 SK BIOSCIENCE LTD Health Care Equity 2211444.87 2.09
GERN GERON CORP Health Care Equity 2058148.8 1.95
ABCL ABCELLERA BIOLOGICS INC Health Care Equity 1858250.52 1.76
VERV VERVE THERAPEUTICS INC Health Care Equity 1786378.56 1.69
IMNM IMMUNOME INC Health Care Equity 1727893.5 1.63
XNCR XENCOR INC Health Care Equity 1270301.76 1.2
RCUS ARCUS BIOSCIENCES INC Health Care Equity 1258012.58 1.19
KURA KURA ONCOLOGY INC Health Care Equity 1148501.19 1.09
IOVA IOVANCE BIOTHERAPEUTICS INC Health Care Equity 1129993.56 1.07
VIR VIR BIOTECHNOLOGY INC Health Care Equity 1086190.56 1.03
DNA GINKGO BIOWORKS HOLDINGS INC CLASS Materials Equity 1017708.75 0.96
CELC CELCUITY INC Health Care Equity 996217.05 0.94
ORIC ORIC PHARMACEUTICALS INC Health Care Equity 980023.1 0.93
VLA VALNEVA Health Care Equity 950518.23 0.9
MREO MEREO BIOPHARMA GROUP ADR REPRESEN Health Care Equity 943061.03 0.89
PACB PACIFIC BIOSCIENCES OF CALIFORNIA Health Care Equity 792368.68 0.75
RIGL RIGEL PHARMACEUTICALS INC Health Care Equity 787109.52 0.74
ARCT ARCTURUS THERAPEUTICS HOLDINGS INC Health Care Equity 780990.3 0.74
IBRX IMMUNITYBIO INC Health Care Equity 585414.72 0.55
CRSP CRISPR THERAPEUTICS AG Health Care Equity 380851.2 0.36
4528 ONO PHARMACEUTICAL LTD Health Care Equity 356170.17 0.34
USD USD CASH Cash and/or Derivatives Cash 221874.23 0.21
LGND LIGAND PHARMACEUTICALS INC Health Care Equity 202123.04 0.19
BEAM BEAM THERAPEUTICS INC Health Care Equity 141472.17 0.13
JPY JPY CASH Cash and/or Derivatives Cash 110933.54 0.1
NTLA INTELLIA THERAPEUTICS INC Health Care Equity 86474.22 0.08
GBP GBP CASH Cash and/or Derivatives Cash 68499.64 0.06
XTSLA BLK CSH FND TREASURY SL AGENCY Cash and/or Derivatives Money Market 30000.0 0.03
HBCFT CASH COLLATERAL USD HBCFT Cash and/or Derivatives Cash Collateral and Margins 25000.0 0.02
EUR EUR CASH Cash and/or Derivatives Cash 11962.8 0.01
KRW KRW CASH Cash and/or Derivatives Cash 9904.97 0.01
CHF CHF CASH Cash and/or Derivatives Cash 8498.56 0.01
DKK DKK CASH Cash and/or Derivatives Cash 6751.97 0.01
HKD HKD CASH Cash and/or Derivatives Cash 3888.44 0.0
TWD TWD CASH Cash and/or Derivatives Cash 180.03 0.0
nan OMNIAB INC $15.00 VESTING Prvt Health Care Equity 0.19 0.0
nan OMNIAB INC $12.50 VESTING Prvt Health Care Equity 0.19 0.0
IXCU5 E-MINI HEALTH CARE SECTOR SEP 25 Cash and/or Derivatives Futures 0.0 0.0
The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See www.iShares.com for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY BEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Bloomberg, BlackRock Index Services, LLC, Cboe Global Indices, LLC, Cohen & Steers, European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Indices, LLC, NSE Indices Ltd, JPMorgan, JPX Group, London Stock Exchange Group (“LSEG”), MSCI Inc., Markit Indices Limited, Morningstar, Inc., Nasdaq, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), Nikkei, Inc., Russell, S&P Dow Jones Indices LLC or STOXX Ltd. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE, LSEG, nor NAREIT makes any warranty regarding the FTSE Nareit Equity REITS Index, FTSE Nareit All Residential Capped Index or FTSE Nareit All Mortgage Capped Index. Neither FTSE, EPRA, LSEG, nor NAREIT makes any warranty regarding the FTSE EPRA Nareit Developed ex-U.S. Index, FTSE EPRA Nareit Developed Green Target Index or FTSE EPRA Nareit Global REITs Index. “FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2023 BlackRock, Inc or its affiliates. All rights reserved. iSHARES, iBONDS and BLACKROCK are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners. nan nan nan nan nan